The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection

Minerva Med. 2021 Aug;112(4):514-516. doi: 10.23736/S0026-4806.21.07487-5. Epub 2021 Mar 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / prevention & control*
  • Child
  • Humans
  • Probiotics / therapeutic use*
  • Streptococcus salivarius*